JOHN KIRBY TOMPKINS

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family STONE HARBOR, NJ NPI 1306247457

General Payments — all program years on this page

$626.94

  • Category: General Payments
  • Program years: PY2021–2023
  • Record count: 36
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $360.48 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $355.3116
Education $5.171

By paying entity

Latest program year (PY2023) · sorted by reported total.

Paying entityAmountRecords
Supernus Pharmaceuticals, Inc. $299.5613
IRONSHORE PHARMACEUTICALS INC. $44.363
GlaxoSmithKline, LLC. $16.561

By program year

Program yearAmountRecords
2021 $208.3915
2022 $58.074
2023 $360.4817

Records — PY2023 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1004110599 GlaxoSmithKline, LLC. $16.56 04/25/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1053439573 Supernus Pharmaceuticals, Inc. $26.05 01/20/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1053439575 Supernus Pharmaceuticals, Inc. $18.26 01/25/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1053439579 Supernus Pharmaceuticals, Inc. $13.02 02/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1053439583 Supernus Pharmaceuticals, Inc. $23.90 03/15/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1053439587 Supernus Pharmaceuticals, Inc. $13.38 04/03/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1053439589 Supernus Pharmaceuticals, Inc. $15.58 04/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1053439593 Supernus Pharmaceuticals, Inc. $19.54 05/22/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1053439597 Supernus Pharmaceuticals, Inc. $31.56 08/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1053439601 Supernus Pharmaceuticals, Inc. $5.17 08/04/2023 Education Undisputed 01/23/2026 View at CMS
1053439603 Supernus Pharmaceuticals, Inc. $46.43 08/05/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1053439607 Supernus Pharmaceuticals, Inc. $33.03 08/28/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1053439611 Supernus Pharmaceuticals, Inc. $19.44 08/28/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1053439615 Supernus Pharmaceuticals, Inc. $34.20 08/29/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1060489087 Ironshore Pharmaceuticals Inc. $14.78 02/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1060489155 Ironshore Pharmaceuticals Inc. $14.89 01/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1060489303 Ironshore Pharmaceuticals Inc. $14.69 03/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.